Kathleen Mulligan, PhD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address2540 23rd Street, #4408
San Francisco CA 94110
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Endocrine Society2009  - 2010Endocrine Society/Pfizer International Award for Excellence in Published Clinical Research

    Collapse Overview 
    Collapse Overview
    I study the nutritional and metabolic effects of chronic conditions including HIV infection and its therapies, obesity, fatty liver disease, and type 2 diabetes, with a focus on body composition, glucose and lipid metabolism, endocrine function, and bone metabolism; and a strong emphasis on treatments and mechanisms. My research has ranged from leading intense inpatient metabolic ward studies to chairing multicenter trials through consortia such as the adult and pediatric AIDS Clinical Trials Groups and Adolescent Trials Network.

    Collapse Research 
    Collapse Research Activities and Funding
    UCSF Nutrition Obesity Research Center
    NIH P30DK098722Aug 1, 2015 - Jul 31, 2025
    Role: Co-Investigator
    Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
    NIH R01HL113887Jun 1, 2013 - May 31, 2021
    Role: Co-Principal Investigator
    METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
    NIH R01DK054615Sep 30, 1998 - Aug 31, 2005
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination. Nat Nanotechnol. 2024 Jul; 19(7):1055-1065. Zeng YC, Young OJ, Wintersinger CM, Anastassacos FM, MacDonald JI, Isinelli G, Dellacherie MO, Sobral M, Bai H, Graveline AR, Vernet A, Sanchez M, Mulligan K, Choi Y, Ferrante TC, Keskin DB, Fell GG, Neuberg D, Wu CJ, Mooney DJ, Kwon IC, Ryu JH, Shih WM. PMID: 38491184.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    2. Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care: Time-and-Motion Cost Analysis. Inquiry. 2023 Jan-Dec; 60:469580231218625. Nuckols TK, Berdahl CT, Henreid AJ, Schnipper JL, Rauf A, Ko EM, Nguyen AT, Co Z, Fanikos J, Kim JH, Leang DW, Matta L, Mulligan K, Ray A, Shane R, Wassef K, Pevnick JM. PMID: 38146178; PMCID: PMC10752096.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. An Analysis of Information Sources of YouTube Videos Pertaining to Tattoo Removal: Cross-Sectional Study. JMIR Dermatol. 2022 Oct-Dec; 5(4). Gallo Marin B, Ezemma O, Frech FS, Flores Servin JC, Rhee BS, Mulligan KM, O'Connell KA, Moseley I, Wambier CG. PMID: 36419716; PMCID: PMC9681016.
      View in: PubMed   Mentions: 1  
    4. Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones. AIDS Res Hum Retroviruses. 2022 11; 38(11):840-846. Yager J, Brooks KM, Brothers J, Mulligan K, Landovitz R, Reirden D, Glenny C, Malhotra M, Anderson PL, Hosek S. PMID: 35943868; PMCID: PMC9910104.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    5. Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate. AIDS Res Hum Retroviruses. 2022 12; 38(12):939-943. Yager J, Brooks KM, Brothers J, Mulligan K, Landovitz RJ, Reirden D, Malhotra M, Glenny C, Harding P, Powell T, Anderson PL, Hosek S. PMID: 35815468; PMCID: PMC9910105.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    6. Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity. Nutrients. 2022 Mar 30; 14(7). Olson E, Suh JH, Schwarz JM, Noworolski SM, Jones GM, Barber JR, Erkin-Cakmak A, Mulligan K, Lustig RH, Mietus-Snyder M. PMID: 35406045; PMCID: PMC9002884.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    7. Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113. Clin Infect Dis. 2020 02 03; 70(4):687-691. Havens PL, Perumean-Chaney SE, Patki A, Cofield SS, Wilson CM, Liu N, Anderson PL, Landovitz RJ, Kapogiannis BG, Hosek SG, Mulligan K. PMID: 31179503; PMCID: PMC7319267.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    8. Separation of postprandial lipoproteins: improved purification of chylomicrons using an ApoB100 immunoaffinity method. J Lipid Res. 2020 03; 61(3):455-463. Jones GM, Caccavello R, Palii SP, Pullinger CR, Kane JP, Mulligan K, Gugliucci A, Schwarz JM. PMID: 31888979; PMCID: PMC7053834.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    9. Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome. J Clin Endocrinol Metab. 2019 07 01; 104(7):3003-3011. Erkin-Cakmak A, Bains Y, Caccavello R, Noworolski SM, Schwarz JM, Mulligan K, Lustig RH, Gugliucci A. PMID: 30869790; PMCID: PMC6553815.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    10. Effect of Vitamin D Supplementation on Bone Turnover Markers During HIV Pre-Exposure Prophylaxis Using Tenofovir Disoproxil Fumarate-Emtricitabine in Men Who Have Sex with Men. AIDS Res Hum Retroviruses. 2019 07; 35(7):608-614. Nanayakkara DD, Sun X, Morris S, Louie S, Mulligan K, Overton T, Asante I, Corado K, Jain S, Dubé MP. PMID: 30907095.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    11. Changes in Lean Mass, Absolute and Relative Muscle Strength, and Physical Performance After Gastric Bypass Surgery. J Clin Endocrinol Metab. 2019 03 01; 104(3):711-720. Alba DL, Wu L, Cawthon PM, Mulligan K, Lang T, Patel S, King NJ, Carter JT, Rogers SJ, Posselt AM, Stewart L, Shoback DM, Schafer AL. PMID: 30657952; PMCID: PMC6339456.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    12. Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis. AIDS Res Hum Retroviruses. 2019 02; 35(2):123-128. Havens PL, Tamhane A, Stephensen CB, Schuster GU, Gordon CM, Liu N, Wilson CM, Hosek SG, Anderson PL, Kapogiannis BG, Mulligan K. PMID: 30280906; PMCID: PMC6360393.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    13. Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone. Antivir Ther. 2018; 23(7):623-628. Havens PL, Long D, Schuster GU, Gordon CM, Price G, Wilson CM, Kapogiannis BG, Mulligan K, Stephensen CB, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 117 and 109 study teams. PMID: 30260797.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    14. Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine. Clin Infect Dis. 2018 07 18; 67(3):411-419. Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM. PMID: 29415175; PMCID: PMC6051460.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    15. Dietary carbohydrates and fatty liver disease: de novo lipogenesis. Curr Opin Clin Nutr Metab Care. 2018 07; 21(4):277-282. Chiu S, Mulligan K, Schwarz JM. PMID: 29697539.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    16. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial. Clin Infect Dis. 2018 01 06; 66(2):220-228. Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Harris DR, Price G, Baker A, Meyer WA, Wilson CM, Hazra R, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 109 Study Team. PMID: 29020329; PMCID: PMC5848310.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    17. The Association of Fat and Lean Tissue With Whole Body and Spine Bone Mineral Density Is Modified by HIV Status and Sex in Children and Youth. Pediatr Infect Dis J. 2018 Jan; 37(1):71-77. Jacobson DL, Lindsey JC, Coull BA, Mulligan K, Bhagwat P, Aldrovandi GM, Pediatric AIDS Clinical Trials Group P1045 Team. PMID: 28817419; PMCID: PMC5725259.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States. JAMA Pediatr. 2017 11 01; 171(11):1063-1071. Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, Harris DR, Mulligan K, Zimet G, Mayer KH, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM. PMID: 28873128; PMCID: PMC5710370.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    19. Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis. J Acquir Immune Defic Syndr. 2017 10 01; 76(2):177-182. Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM. PMID: 28639995; PMCID: PMC5597476.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    20. Conversion of Sugar to Fat: Is Hepatic de Novo Lipogenesis Leading to Metabolic Syndrome and Associated Chronic Diseases? J Am Osteopath Assoc. 2017 Aug 01; 117(8):520-527. Schwarz JM, Clearfield M, Mulligan K. PMID: 28759094.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    21. Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. Gastroenterology. 2017 09; 153(3):743-752. Schwarz JM, Noworolski SM, Erkin-Cakmak A, Korn NJ, Wen MJ, Tai VW, Jones GM, Palii SP, Velasco-Alin M, Pan K, Patterson BW, Gugliucci A, Lustig RH, Mulligan K. PMID: 28579536; PMCID: PMC5813289.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    22. Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study. F1000Res. 2017; 6:614. Lee AP, Mulligan K, Schambelan M, Murphy EJ, Weiss EJ. PMID: 28713554; PMCID: PMC5499778.
      View in: PubMed   Mentions: 4     Fields:    
    23. An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. J Acquir Immune Defic Syndr. 2017 01 01; 74(1):21-29. Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Mulligan K, Zimet G, Lally M, Mayer KH, Anderson P, Kiser J, Rooney JF, Wilson CM, Adolescent Trials Network (ATN) for HIVAIDS Interventions. PMID: 27632233; PMCID: PMC5140725.
      View in: PubMed   Mentions: 157     Fields:    Translation:HumansPHPublic Health
    24. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis. Clin Infect Dis. 2017 Feb 01; 64(3):317-325. Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N, Wilson CM, Hazra R, Hosek SG, Anderson PL, Seifert SM, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions 117 study team. PMID: 28013265; PMCID: PMC6366053.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    25. Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021. J Acquir Immune Defic Syndr. 2016 08 01; 72(4):372-5. Ruan A, Tobin NH, Mulligan K, Rollie A, Li F, Sleasman J, Aldrovandi GM. PMID: 26885808; PMCID: PMC4925249.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    26. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. Atherosclerosis. 2016 10; 253:171-177. Gugliucci A, Lustig RH, Caccavello R, Erkin-Cakmak A, Noworolski SM, Tai VW, Wen MJ, Mulligan K, Schwarz JM. PMID: 27451002.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    27. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring). 2016 Feb; 24(2):453-60. Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, Gugliucci A, Schwarz JM. PMID: 26499447; PMCID: PMC4736733.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    28. Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey. Rheumatology (Oxford). 2015 Nov; 54(11):2108-9. Amin TS, Shenton S, Mulligan K, Wedderburn LR, Wood M, VanRooyen V, Leone V. PMID: 26209331.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis. 2015 Aug 15; 61(4):572-80. Mulligan K, Glidden DV, Anderson PL, Liu A, McMahan V, Gonzales P, Ramirez-Cardich ME, Namwongprom S, Chodacki P, de Mendonca LM, Wang F, Lama JR, Chariyalertsak S, Guanira JV, Buchbinder S, Bekker LG, Schechter M, Veloso VG, Grant RM, Preexposure Prophylaxis Initiative Study Team. PMID: 25908682; PMCID: PMC4565984.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    30. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. J Clin Endocrinol Metab. 2015 Jun; 100(6):2434-42. Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai VW, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K. PMID: 25825943; PMCID: PMC4454806.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCellsCTClinical Trials
    31. Subchronic sleep restriction causes tissue-specific insulin resistance. J Clin Endocrinol Metab. 2015 Apr; 100(4):1664-71. Rao MN, Neylan TC, Grunfeld C, Mulligan K, Schambelan M, Schwarz JM. PMID: 25658017; PMCID: PMC4399283.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    32. Thermogenic changes after gastric bypass, adjustable gastric banding or diet alone. Surgery. 2014 Oct; 156(4):806-12. Rabl C, Rao MN, Schwarz JM, Mulligan K, Campos GM. PMID: 25239323; PMCID: PMC4171693.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    33. Exploration of the Effect of Tobacco Smoking on Metabolic Measures in Young People Living with HIV. AIDS Res Treat. 2014; 2014:740545. Rubinstein ML, Harris DR, Rudy BJ, Kapogiannis BG, Aldrovandi GM, Mulligan K. PMID: 25114801; PMCID: PMC4119894.
      View in: PubMed   Mentions: 2  
    34. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS. 2014 Mar 27; 28(6):851-9. Solomon MM, Lama JR, Glidden DV, Mulligan K, McMahan V, Liu AY, Guanira JV, Veloso VG, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Burns DN, Grant RM, iPrEx Study Team. PMID: 24499951; PMCID: PMC3966916.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    35. Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate. Antivir Ther. 2014; 19(6):613-8. Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 study team. PMID: 24535626; PMCID: PMC4135028.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    36. Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein. Front Genet. 2013; 4:234. Porter TR, Li X, Stephensen CB, Mulligan K, Rutledge B, Flynn PM, Lujan-Zilbermann J, Hazra R, Wilson CM, Havens PL, Tang J, Adolescent MedicineTrials Network for HIV/AIDS Interventions (ATN) 063 study team. PMID: 24294218; PMCID: PMC3827582.
      View in: PubMed   Mentions: 3  
    37. The Official Positions of the International Society for Clinical Densitometry: Indications of Use and Reporting of DXA for Body Composition. J Clin Densitom. 2013 Oct-Dec; 16(4):496-507. Kendler DL, Borges JL, Fielding RA, Itabashi A, Krueger D, Mulligan K, Camargos BM, Sabowitz B, Wu CH, Yu EW, Shepherd J. PMID: 24090645.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    38. The Official Positions of the International Society for Clinical Densitometry: body composition analysis reporting. J Clin Densitom. 2013 Oct-Dec; 16(4):508-19. Petak S, Barbu CG, Yu EW, Fielding R, Mulligan K, Sabowitz B, Wu CH, Shepherd JA. PMID: 24183640.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    39. Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy. Dermatol Res Pract. 2013; 2013:941740. Khanijow K, Unemori P, Leslie KS, Mulligan K, Schambelan M, Maurer T. PMID: 24159328; PMCID: PMC3789479.
      View in: PubMed   Mentions: 1  
    40. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 2013 Nov; 57(11):5619-28. Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 Study Team. PMID: 24002093; PMCID: PMC3811269.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    41. Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery. Surg Obes Relat Dis. 2014 Jan-Feb; 10(1):1-8. Campos GM, Rabl C, Havel PJ, Rao M, Schwarz JM, Schambelan M, Mulligan K. PMID: 24209879; PMCID: PMC3896512.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    42. Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection. J Clin Endocrinol Metab. 2012 Nov; 97(11):4004-13. Havens PL, Mulligan K, Hazra R, Flynn P, Rutledge B, Van Loan MD, Lujan-Zilbermann J, Kapogiannis BG, Wilson CM, Stephensen CB, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 Study Team. PMID: 22933542; PMCID: PMC3485594.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    43. Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men. AIDS Res Treat. 2012; 2012:103072. Rao MN, Schambelan M, Tai VW, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K. PMID: 22966425; PMCID: PMC3433112.
      View in: PubMed   Mentions: 2  
    44. Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B. Clin Infect Dis. 2012 Aug; 55(3):461-8. Mulligan K, Harris DR, Emmanuel P, Fielding RA, Worrell C, Kapogiannis BG, Monte D, Sleasman J, Wilson CM, Aldrovandi GM, ATN 021 Protocol team. PMID: 22573848; PMCID: PMC3491777.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    45. Using cluster heat maps to investigate relationships between body composition and laboratory measurements in HIV-infected and HIV-uninfected children and young adults. J Acquir Immune Defic Syndr. 2012 Mar 01; 59(3):325-8. Lindsey JC, Jacobson DL, Li H, Houseman EA, Aldrovandi GM, Mulligan K. PMID: 22083069; PMCID: PMC3288740.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    46. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin Infect Dis. 2012 Apr; 54(7):1013-25. Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions 063 study team. PMID: 22267714; PMCID: PMC3297650.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    47. Dual-energy X-ray absorptiometry-based body volume measurement for 4-compartment body composition. Am J Clin Nutr. 2012 Jan; 95(1):25-31. Wilson JP, Mulligan K, Fan B, Sherman JL, Murphy EJ, Tai VW, Powers CL, Marquez L, Ruiz-Barros V, Shepherd JA. PMID: 22134952; PMCID: PMC3238462.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    48. Executive summary--nutritional care of HIV-infected adolescents and adults, including pregnant and lactating women: what do we know, what can we do, and where do we go from here? Am J Clin Nutr. 2011 Dec; 94(6):1667S-1676S. Raiten DJ, Mulligan K, Papathakis P, Wanke C. PMID: 22089438; PMCID: PMC3226019.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One. 2011; 6(8):e23688. Liu AY, Vittinghoff E, Sellmeyer DE, Irvin R, Mulligan K, Mayer K, Thompson M, Grant R, Pathak S, O'Hara B, Gvetadze R, Chillag K, Grohskopf L, Buchbinder SP. PMID: 21897852; PMCID: PMC3163584.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    50. Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle. PLoS One. 2011 May 11; 6(5):e19878. Masharani UB, Maddux BA, Li X, Sakkas GK, Mulligan K, Schambelan M, Goldfine ID, Youngren JF. PMID: 21589939; PMCID: PMC3092773.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    51. Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. PLoS One. 2011 Feb 17; 6(2):e14709. Weinberg ME, Roman MC, Jacob P, Wen M, Cheung P, Walker UA, Mulligan K, Schambelan M. PMID: 21379380; PMCID: PMC3040752.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    52. Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin Infect Dis. 2011 Apr 01; 52(7):941-4. Choi AI, Lo JC, Mulligan K, Schnell A, Kalapus SC, Li Y, Hunt PW, Martin JN, Deeks SG, Hsue PY. PMID: 21273298; PMCID: PMC3106229.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    53. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30; 363(27):2587-99. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV, iPrEx Study Team. PMID: 21091279; PMCID: PMC3079639.
      View in: PubMed   Mentions: 2527     Fields:    Translation:HumansCells
    54. Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers. J Acquir Immune Defic Syndr. 2010 Nov; 55(3):361-4. Taylor SA, Lee GA, Pao VY, Anthonypillai J, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. PMID: 20595906; PMCID: PMC3164483.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. J Clin Endocrinol Metab. 2010 Sep; 95(9):4361-6. Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M. PMID: 20610601; PMCID: PMC2936071.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    56. Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045. AIDS. 2010 Mar 13; 24(5):687-96. Jacobson DL, Lindsey JC, Gordon CM, Moye J, Hardin DS, Mulligan K, Aldrovandi GM, Pediatric AIDS Clinical Trials Group P1045 team. PMID: 20168204; PMCID: PMC3154736.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    57. The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers. AIDS. 2010 Jan 16; 24(2):265-70. Pao VY, Lee GA, Taylor S, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. PMID: 19890203.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    58. A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy. HIV Clin Trials. 2010 Jan-Feb; 11(1):39-50. Raboud JM, Diong C, Carr A, Grinspoon S, Mulligan K, Sutinen J, Rozenbaum W, Cavalcanti RB, Wand H, Costagliola D, Walmsley S, Glitazone and Lipoatrophy Meta-Analysis Working Group. PMID: 20400410; PMCID: PMC3733492.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    59. Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. Clin Infect Dis. 2010 Jan 01; 50(1):106-14. Mulligan K, Harris DR, Monte D, Stoszek S, Emmanuel P, Hardin DS, Kapogiannis BG, Worrell C, Meyer WA, Sleasman J, Wilson CM, Aldrovandi GM, Adolescent Trials Network 021 Protocol Team. PMID: 19947855; PMCID: PMC2939739.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    60. Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting? Curr Opin Clin Nutr Metab Care. 2009 Nov; 12(6):623-7. Sakkas GK, Schambelan M, Mulligan K. PMID: 19741514; PMCID: PMC2905310.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg. 2010 Jan; 14(1):15-23. Campos GM, Rabl C, Peeva S, Ciovica R, Rao M, Schwarz JM, Havel P, Schambelan M, Mulligan K. PMID: 19838759; PMCID: PMC2793380.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    62. The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):246-8. Lee GA, Schwarz JM, Patzek S, Kim S, Dyachenko A, Wen M, Mulligan K, Schambelan M, Grunfeld C. PMID: 19680131; PMCID: PMC3164488.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    63. Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. AIDS. 2009 Mar 27; 23(6):661-72. Aldrovandi GM, Lindsey JC, Jacobson DL, Zadzilka A, Sheeran E, Moye J, Borum P, Meyer WA, Hardin DS, Mulligan K, Pediatric AIDS Clinical Trials Group P1045 team. PMID: 19279441; PMCID: PMC2680185.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCellsPHPublic Health
    64. Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study. PLoS One. 2009; 4(2):e4605. Sakkas GK, Mulligan K, Dasilva M, Doyle JW, Khatami H, Schleich T, Kent-Braun JA, Schambelan M. PMID: 19242554; PMCID: PMC2646129.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    65. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab. 2009 Apr; 94(4):1137-44. Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, Wen MJ, Lee GA, Grunfeld C, Schambelan M. PMID: 19174500; PMCID: PMC2682465.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    66. Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial. Am J Clin Nutr. 2008 Nov; 88(5):1313-21. Sattler FR, Rajicic N, Mulligan K, Yarasheski KE, Koletar SL, Zolopa A, Alston Smith B, Zackin R, Bistrian B, ACTG 392 Study Team. PMID: 18996868; PMCID: PMC2797483.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    67. Factors associated with weight loss after gastric bypass. Arch Surg. 2008 Sep; 143(9):877-883; discussion 884. Campos GM, Rabl C, Mulligan K, Posselt A, Rogers SJ, Westphalen AC, Lin F, Vittinghoff E. PMID: 18794426; PMCID: PMC2747804.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    68. Genetic analysis implicates resistin in HIV lipodystrophy. AIDS. 2008 Aug 20; 22(13):1561-8. Ranade K, Geese WJ, Noor M, Flint O, Tebas P, Mulligan K, Powderly W, Grinspoon SK, Dube MP. PMID: 18670214; PMCID: PMC4410015.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    69. Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2008 Jul 01; 48(3):272-80. Sobieszczyk ME, Hoover DR, Anastos K, Mulligan K, Tan T, Shi Q, Gao W, Hyman C, Cohen MH, Cole SR, Plankey MW, Levine AM, Justman J, Women's Interagency HIV Study. PMID: 18545157.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    70. Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. Circulation. 2008 Jul 08; 118(2):e20-8. Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P, Masur H, Meigs JB, Mulligan K, Reiss P, Samaras K, Working Group 1. PMID: 18566314; PMCID: PMC3170411.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    71. Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy. J Infect Dis. 2008 Mar 15; 197(6):858-66. Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dubé M, Grinspoon S, Robbins GK, Motsinger AA, Kallianpur AR, AIDS Clinical Trials Group 384 and A5005s Study Teams. PMID: 18419350.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    72. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. AIDS. 2007 Oct 18; 21(16):2183-90. Lee GA, Rao M, Mulligan K, Lo JC, Aweeka F, Schwarz JM, Schambelan M, Grunfeld C. PMID: 18090045; PMCID: PMC3167072.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    73. Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384. J Acquir Immune Defic Syndr. 2007 Aug 15; 45(5):508-14. Dubé MP, Komarow L, Mulligan K, Grinspoon SK, Parker RA, Robbins GK, Roubenoff R, Tebas P, Adult Clinical Trials Group 384. PMID: 17589373.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    74. Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T. Magn Reson Imaging. 2008 Feb; 26(2):188-97. Li X, Youngren JF, Hyun B, Sakkas GK, Mulligan K, Majumdar S, Masharani UB, Schambelan M, Goldfine ID. PMID: 17683890; PMCID: PMC2713003.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    75. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384. Clin Infect Dis. 2007 Jul 01; 45(1):120-6. Dubé MP, Parker RA, Mulligan K, Tebas P, Robbins GK, Roubenoff R, Grinspoon SK. PMID: 17554712.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    76. Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. AIDS. 2007 Jan 02; 21(1):47-57. Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S. PMID: 17148967.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    77. The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther. 2007; 12(7):1049-58. Anastos K, Lu D, Shi O, Mulligan K, Tien PC, Freeman R, Cohen MH, Justman J, Hessol NA. PMID: 18018763.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    78. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ. 2007 Jan 06; 334(7583):25. Brown CT, Yap T, Cromwell DA, Rixon L, Steed L, Mulligan K, Mundy A, Newman SP, van der Meulen J, Emberton M. PMID: 17118949; PMCID: PMC1764065.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    79. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab. 2007 Feb; 92(2):563-70. Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M, ACTG 313 Study Team. PMID: 17090640.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    80. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis. 2006 Sep 01; 43(5):645-53. Wohl DA, McComsey G, Tebas P, Brown TT, Glesby MJ, Reeds D, Shikuma C, Mulligan K, Dube M, Wininger D, Huang J, Revuelta M, Currier J, Swindells S, Fichtenbaum C, Basar M, Tungsiripat M, Meyer W, Weihe J, Wanke C. PMID: 16886161.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    81. Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. Clin Infect Dis. 2006 Sep 01; 43(5):658-60. Lee GA, Lo JC, Aweeka F, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. PMID: 16886163; PMCID: PMC3205942.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    82. Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial. J Acquir Immune Defic Syndr. 2006 Apr 15; 41(5):590-7. Mulligan K, Parker RA, Komarow L, Grinspoon SK, Tebas P, Robbins GK, Roubenoff R, Dubé MP. PMID: 16652032.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    83. Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides. AIDS. 2005 Nov 04; 19(16):1807-18. Dubé MP, Parker RA, Tebas P, Grinspoon SK, Zackin RA, Robbins GK, Roubenoff R, Shafer RW, Wininger DA, Meyer WA, Snyder SW, Mulligan K. PMID: 16227788.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    84. The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection. Clin Infect Dis. 2005 Nov 01; 41(9):1335-40. Lo JC, Kazemi MR, Hsue PY, Martin JN, Deeks SG, Schambelan M, Mulligan K. PMID: 16206112.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    85. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. J Acquir Immune Defic Syndr. 2005 May 01; 39(1):55-62. Danoff A, Shi Q, Justman J, Mulligan K, Hessol N, Robison E, Lu D, Williams T, Wichienkuer P, Anastos K, Women's Interagency HIV Study (WIHS). PMID: 15851914.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    86. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. Arch Intern Med. 2005 Mar 14; 165(5):578-85. Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, Delvers TB, Currier JS, AIDS Clinical Trials Group 329 Study Team, National Institute of Allergy and Infectious Diseases Adult AIDS Clinical Trials Group. PMID: 15767536.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    87. Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):18-22. Mulligan K, Anastos K, Justman J, Freeman R, Wichienkuer P, Robison E, Hessol NA. PMID: 15608519.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    88. The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy. Clin Chem Lab Med. 2005; 43(9):947-52. Dubé MP, Kitch DW, Parker RA, Alston-Smith BL, Mulligan K. PMID: 16176175.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    89. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis. 2004 Oct 15; 39(8):1223-30. Shikuma CM, Zackin R, Sattler F, Mildvan D, Nyangweso P, Alston B, Evans S, Mulligan K, AIDS Clinical Trial Group 892 Team. PMID: 15486848.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    90. Indinavir increases glucose production in healthy HIV-negative men. AIDS. 2004 Sep 03; 18(13):1852-4. Schwarz JM, Lee GA, Park S, Noor MA, Lee J, Wen M, Lo JC, Mulligan K, Schambelan M, Grunfeld C. PMID: 15316349.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    91. The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. Clin Infect Dis. 2004 Sep 01; 39(5):732-5. Lo JC, Mulligan K, Noor MA, Lee GA, Schwarz JM, Grunfeld C, Schambelan M. PMID: 15356790; PMCID: PMC3170406.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    92. HIV protease inhibitors increase adiponectin levels in HIV-negative men. J Acquir Immune Defic Syndr. 2004 May 01; 36(1):645-7. Lee GA, Mafong DD, Noor MA, Lo JC, Mulligan K, Schwarz JM, Schambelan M, Grunfeld C. PMID: 15097312.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    93. The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS. 2004 Mar 05; 18(4):641-9. Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C. PMID: 15090769; PMCID: PMC3166345.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    94. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003 Aug 19; 139(4):258-66. Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. PMID: 12965981.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCellsCTClinical Trials
    95. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003 Apr 01; 36(Suppl 2):S69-78. Grinspoon S, Mulligan K, Department of Health and Human Services Working Group on the Prevention and Treatment of Wasting and. PMID: 12652374.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    96. Metabolic abnormalities in patients with HIV infection. J Int Assoc Physicians AIDS Care (Chic). 2003 Apr-Jun; 2(2):66-74. Mulligan K. PMID: 12961760.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    97. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002 Nov 01; 31(3):257-75. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS, International AIDS Society-USA. PMID: 12439201.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    98. Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting. Clin Infect Dis. 2002 Nov 15; 35(10):1258-62. Tai VW, Schambelan M, Algren H, Shayevich C, Mulligan K. PMID: 12410487.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    99. Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol. 2002 Sep; 85(1):151-9. Mulligan K, Schambelan M. PMID: 12163220.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    100. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS. 2002 May 24; 16(8):1103-11. Napolitano LA, Lo JC, Gotway MB, Mulligan K, Barbour JD, Schmidt D, Grant RM, Halvorsen RA, Schambelan M, McCune JM. PMID: 12004268.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCellsCTClinical Trials
    101. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002 Mar 29; 16(5):F1-8. Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. PMID: 11964551; PMCID: PMC3166537.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    102. Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab. 2002 Feb; 87(2):942. Schwarz JM, Mulligan K, Lee J, Lo JC, Wen M, Noor MA, Grunfeld C, Schambelan M. PMID: 11836345.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    103. Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies. J Infect Dis. 2001 Nov 15; 184(10):1325-7. Clark RA, Mulligan K, Stamenovic E, Chang B, Watts H, Andersen J, Squires K, Benson C. PMID: 11679923.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    Kathleen's Networks
    Concepts (385)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (68)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.